Open Access Highly Accessed Research article

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

Jorja D Warren1, Wei Xiong1, Ashley M Bunker2, Cecily P Vaughn2, Larissa V Furtado3, William L Roberts3, John C Fang4, Wade S Samowitz3 and Karen A Heichman13*

Author Affiliations

1 New Technology Group, ARUP Laboratories, Inc., 500 Chipeta Way, Mail Code 209, Salt Lake City, UT 84108-1221, USA

2 ARUP Institute of Experimental Pathology, ARUP Laboratories, Inc., 500 Chipeta Way, Salt Lake City, UT 84108-1221, USA

3 University of Utah Department of Pathology, ARUP Laboratories, Inc., 500 Chipeta Way, Salt Lake City, UT 84108-1221, USA

4 Divison of Gastroenterology, University School of Utah Medicine, 30N 1900 E, Room 4R118, salt Lake City, UT 84132, USA

For all author emails, please log on.

BMC Medicine 2011, 9:133  doi:10.1186/1741-7015-9-133

Published: 14 December 2011

Additional files

Additional file 1:

Supplementary Table 1. Comparison of improved SEPT9 detection protocol with PRESEPT method using analytical specimens.

Format: DOC Size: 31KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 2:

Supplementary Table 2. Measurement of SEPT9 methylated DNA in plasma of colorectal cancer patients.

Format: DOC Size: 100KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 3:

Supplementary Table 3. Control Plasma Specimens.

Format: DOC Size: 178KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data